Advertisement

Magnetic Resonance Imaging of the Epicardial Adipose Tissue

  • Gianluca IacobellisEmail author
Chapter
  • 34 Downloads
Part of the Contemporary Cardiology book series (CONCARD)

Abstract

Epicardial adipose tissue (EAT) is a measurable risk factor and marker of visceral adipose tissue. Magnetic resonance imaging (MRI) is considered the gold standard technique to measure the adipose tissue, also because it does not require ionizing radiations. Dedicated cardiac magnetic resonance (CMR) imaging protocols have been developed to assess EAT volume. CMR provides a precise and noninvasive assessment of both EAT thickness and volume. As EAT is not equally distributed through the heart and when abundant may fill in folding spaces, steady-state free precession (SSFP) sequences of CMR should be used to more accurately measure the different and deeper EAT locations. Proton magnetic resonance spectroscopy (1H-MRS) is the gold standard technique to measure myocardial triglyceride content that is independently correlated with ultrasound measured EAT thickness.

Keywords

Epicardial fat Epicardial adipose tissue Cardiac magnetic resonance imaging Proton magnetic resonance spectroscopy 

References

  1. 1.
    Iacobellis G, Willens HJ. Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr. 2009;22:1311–9.CrossRefGoogle Scholar
  2. 2.
    Iacobellis G, Assael F, Ribaudo MC, Zappaterreno A, Alessi G, Di Mario U, et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res. 2003;11:304–10.CrossRefGoogle Scholar
  3. 3.
    Gronemeyer SA, Steen RG, Kauffman WM, Reddick WE, Glass JO. Fast adipose tissue (FAT) assessment by MRI. Magn Reson Imaging. 2000;18:815–8.CrossRefGoogle Scholar
  4. 4.
    Flüchter S, Haghi D, Dinter D, Heberlein W, Kühl HP, Neff W, et al. Volumetric assessment of epicardial adipose tissue with cardiovascular magnetic resonance imaging. Obesity (Silver Spring). 2007;15:870–8.CrossRefGoogle Scholar
  5. 5.
    Schejbal V. Epicardial fatty tissue of the right ventricle--morphology, morphometry and functional significance. Pneumologie. 1989;43:490–9.PubMedGoogle Scholar
  6. 6.
    Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med. 2005;2:536–43.CrossRefGoogle Scholar
  7. 7.
    Leo LA, Paiocchi VL, Schlossbauer SA, Ho SY, Faletra FF. The intrusive nature of epicardial adipose tissue as revealed by cardiac magnetic resonance. J Cardiovasc Echogr. 2019;29:45.CrossRefGoogle Scholar
  8. 8.
    Mahajan R, Kuklik P, Grover S, Brooks AG, Wong CX, Sanders P, et al. Cardiovascular magnetic resonance of total and atrial pericardial adipose tissue: a validation study and development of a 3-dimensional pericardial adipose tissue model. J Cardiovasc Magn Reson. 2013;29(15):73.CrossRefGoogle Scholar
  9. 9.
    Nelson AJ, Worthley MI, Psaltis PJ, Carbone A, Dundon BK, Duncan RF, et al. Validation of cardiovascular magnetic resonance assessment of pericardial adipose tissue volume. J Cardiovasc Magn Reson. 2009;11:15.CrossRefGoogle Scholar
  10. 10.
    Doesch C, Haghi D, Flüchter S, Suselbeck T, Schoenberg SO, Michaely H, et al. Epicardial adipose tissue in patients with heart failure. J Cardiovasc Magn Reson. 2010;12:40.CrossRefGoogle Scholar
  11. 11.
    Doesch C, Haghi D, Suselbeck T, Schoenberg SO, Borggrefe M, Papavassiliu T. Impact of functional, morphological and clinical parameters on epicardial adipose tissue in patients with coronary artery disease. Circ J. 2012;76:2426–34.CrossRefGoogle Scholar
  12. 12.
    Doesch C, Streitner F, Bellm S, Suselbeck T, Haghi D, Heggemann F, et al. Epicardial adipose tissue assessed by cardiac magnetic resonance imaging in patients with heart failure due to dilated cardiomyopathy. Obesity (Silver Spring). 2013;21:E253–61.CrossRefGoogle Scholar
  13. 13.
    Ng A, Strudwick M, van der Geest RJ, Ng ACC, Gillinder L, Goo SY, et al. Impact of epicardial adipose tissue, left ventricular myocardial fat content and interstitial fibrosis on myocardial contractile function. Circ Cardiovasc Imaging. 2018;11:e007372.CrossRefGoogle Scholar
  14. 14.
    Mahmod M, Bull S, Suttie JJ, Pal N, Holloway C, Dass S, et al. Myocardial steatosis and left ventricular contractile dysfunction in patients with severe aortic stenosis. Circ Cardiovasc Imaging. 2013;6:808–16.CrossRefGoogle Scholar
  15. 15.
    Lu M, Zhao S, Jiang S, Yin G, Wang C, Zhang Y, et al. Fat deposition in dilated cardiomyopathy assessed by CMR. JACC Cardiovasc Imaging. 2013;6:889–98.CrossRefGoogle Scholar
  16. 16.
    Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK, JD MG, Stein DT. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol Endocrinol Metab. 1999;276:E977–89.CrossRefGoogle Scholar
  17. 17.
    Reingold JS, McGavock JM, Kaka S, Tillery T, Victor RG, Szczepaniak LS. Determination of triglyceride in the human myocardium by magnetic resonance spectroscopy: reproducibility and sensitivity of the method. Am J Physiol Endocrinol Metab. 2005;289:E935–9.CrossRefGoogle Scholar
  18. 18.
    Liao PA, Lin G, Tsai SY, Wang CH, Juan YH, Lin YC, et al. Myocardial triglyceride content at 3 T cardiovascular magnetic resonance and left ventricular systolic function: a cross-sectional study in patients hospitalized with acute heart failure. J Cardiovasc Magn Reson. 2016;18:9.CrossRefGoogle Scholar
  19. 19.
    Sai E, Shimada K, Yokoyama T, Hiki M, Sato S, Hamasaki N, et al. Myocardial triglyceride content in patients with left ventricular hypertrophy: comparison between hypertensive heart disease and hypertrophic cardiomyopathy. Heart Vessel. 2017;32:166–74.CrossRefGoogle Scholar
  20. 20.
    Malavazos AE, Di Leo G, Secchi F, Lupo EN, Dogliotti G, Coman C, et al. Relation of echocardiographic epicardial fat thickness and myocardial fat. Am J Cardiol. 2010;105:1831–5.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Division of Endocrinology, Diabetes and Metabolism, Department of MedicineUniversity of Miami, Miller School of MedicineMiamiUSA

Personalised recommendations